术后镇静和呼吸暂停与离子通道变异相关:关于德克斯梅托米丁-普罗波相互作用的病例报告
Gabriele Stocco1,2, Anna Galletti3, Marianna Lucafò4
1Clinical Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
一种SCN9A的遗传变异可能会增加对德克斯米德米丁和普罗波福的长期镇静效应的敏感性. 这一案例突显了儿科患者的潜在风险,建议对个性化麻醉进行药物遗传测试.
科学领域:
- 药物遗传学 药物遗传学
- 儿科麻醉学 儿科麻醉学
- 神经科学是一个神经科学.
背景情况:
- 程序性镇静在儿科患者中很常见,但可能会发生不良事件.
- 德克斯梅德托米丁和普罗波福尔是经常使用的镇静剂,通常是组合使用的.
- 遗传因素可以影响药物代谢和反应,影响镇静的深度和持续时间.
研究的目的:
- 报告一种罕见的复发性镇静和手术镇静后呼吸暂停的病例.
- 调查基因变异在患者不良反应中的潜在作用.
- 强调在儿科镇静中考虑遗传敏感性的重要性.
主要方法:
- 一个患有白血病的青少年经历了静止后并发症的案例报告.
- 基因分析以确定突变,特别是SCN9A基因中的突变.
- 审查患者的镇静史和德克斯梅托米丁和普罗波福尔后的不良事件.
主要成果:
- 患者在手术后出现了反复的自发复静止,呼吸暂停和严重的脱.
- 在SCN9A基因的3'-UTR调节区域中发现了一种新型变异.
- 假设这种变体会影响mRNA的稳定性,增加对联合镇静效应的易感性.
结论:
- 这是第一个儿科病例报告,在联合德克斯梅德托米丁和普罗波镇静后出现晚期复苏和呼吸暂停.
- 遗传变异,如已识别的SCN9A突变,可能会使某些儿科患者容易发生不良镇静事件.
- 药物遗传测试有可能为高风险个体提供个性化麻醉策略.
更多相关视频
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
相关概念视频
Parenteral Anesthetics: Overview
Depolarizing Blockers: Pharmocokinetics
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Stages of General Anesthesia
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
